Anthracene

Anthracene

SCHEMBL245034

c1ccc2cc3c(ccc4ccccc43)cc2c1.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.89
HSD17B10 Q99714 3/20 0.89
CYP1B1 Q16678 2/20 0.89
HIF1A Q16665 1/20 0.89
CYP2A6 P11509 1/20 0.67
TSHR P16473 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
CYP1A2 P05177 3/20 0.61
HPGD P15428 2/20 0.61
HPRT1 P00492 3/20 0.60
ERBB2 P04626 1/20 0.54
FYN P06241 1/20 0.54
MAOA P21397 1/20 0.54
ACHE P22303 1/20 0.54
AHR P35869 1/20 0.54
PAX8 Q06710 1/20 0.48
TRPM4 Q8TD43 1/20 0.48
CYP1A1 P04798 1/20 0.47
MAPT P10636 1/20 0.47
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29352401 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL28804503 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
Phenanthrene SCHEMBL27665236 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
Dibenz[A,H]Anthracene SCHEMBL8873918 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL30384949 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL4853966 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL29362929 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL55324 1.00 ALDH1A1 (0.89) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL1799999 0.97 ALDH1A1 (0.84) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6
SCHEMBL1230609 0.97 ALDH1A1 (0.84) ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221770-B2 Compounds having electron transport properties, their preparation and use MERCK PATENT GMBH (DE) 2015-12-29 US claimed
EP-2318474-B1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE MERCK PATENT GMBH (DE) 2015-05-27 EP claimed
JP-2012500235-A 2012-01-05 JP claimed
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2011-05-12 US claimed
EP-2318474-A1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE Merck Patent GmbH (DE) 2011-05-11 EP claimed
EP-2313383-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE Merck Patent GmbH (DE) 2011-04-27 EP claimed
WO-2010020352-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-25 WO claimed
WO-2010017896-A1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-18 WO claimed
CN-118339941-A Mixed powder and method for producing same, method for producing organic electroluminescent element using same, method for selecting compound in mixed powder, and composition for vacuum vapor deposition 出光兴产株式会社 2024-07-12 CN disclosed
CN-117581654-A Mixed powder, mixed body, and method for manufacturing organic electroluminescent element 出光兴产株式会社 2024-02-20 CN disclosed
CN-111819167-A Material for organic electroluminescent device 默克专利有限公司 2020-10-23 CN disclosed
EP-2318474-B1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE MERCK PATENT GMBH (DE) 2015-05-27 EP disclosed
EP-2318474-A1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE Merck Patent GmbH (DE) 2011-05-11 EP disclosed
WO-2010017896-A1 COMPOUND HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES AND ITS PREPARATION AND USE MERCK PATENT GMBH (DE) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110108819-A1 COMPOUNDS HAVING ELECTRON TRANSPORT PROPERTIES, THEIR PREPARATION AND USE SLC25A21, SLCO4C1, SLCO1B3 ALDH1A1 571/4885HSD17B10 992/4885CYP1B1 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.